Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 8/20 | 0.80 |
| ▸ | FAAH | O00519 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | XBP1 | P17861 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.45 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22311931 | 1.00 | MGLL (0.80) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL13755287 | 1.00 | MGLL (0.80) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL22311910 | 1.00 | MGLL (0.80) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL16006807 | 1.00 | MGLL (0.80) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL30644857 | 1.00 | MGLL (0.80) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL24797392 | 1.00 | MGLL (0.80) | MGLLFAAHALDH1A1LMNAMAPT | |
| Hydrochloric Acid SCHEMBL31681501 | 0.98 | MGLL (0.77) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL7943421 | 0.98 | MGLL (0.76) | MGLLFAAHALDH1A1LMNAMAPT | |
| Hydrochloric Acid SCHEMBL16096501 | 0.96 | MGLL (0.73) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL9643398 | 0.89 | MGLL (1.00) | MGLLFAAHALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122055379-A | Compounds containing one or more diboronate esters and related insulin analogues | 普罗托莫科技公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4694932-A2 | COMPOUNDS CONTAINING ONE OR MORE DIBORONATES AND RELATED INSULIN ANALOGS | Protomer Technologies Inc. (US) | 2026-02-18 | — | — | EP | disclosed |
| US-20250302968-A1 | RADIATION CLEAVED DRUG-CONJUGATE LINKERS ENABLE LOCAL PAYLOAD RELEASE SCLEROSIS | THE GENERAL HOSPITAL CORPORATION | 2025-10-02 | — | — | US | disclosed |
| EP-4525919-A1 | AROMATIC BORON-CONTAINING COMPOUNDS AND RELATED INSULIN ANALOGS | Protomer Technologies Inc. (US) | 2025-03-26 | — | — | EP | disclosed |
| CN-119677541-A | Aromatic boron-containing compounds and related insulin analogues | 原聚体科技公司 | 2025-03-21 | — | — | CN | disclosed |
| EP-4522139-A1 | RADIATION CLEAVED DRUG-CONJUGATE LINKERS ENABLE LOCAL PAYLOAD RELEASE SCLEROSIS | The General Hospital Corporation (US) | 2025-03-19 | — | — | EP | disclosed |
| US-20240425528-A1 | AROMATIC BORON-CONTAINING COMPOUNDS AND RELATED INSULIN ANALOGS | PROTOMER TECH INC (US) | 2024-12-26 | — | — | US | disclosed |
| US-20240400637-A1 | COMPOUNDS CONTAINING ONE OR MORE DIBORONATES AND RELATED INSULIN ANALOGS | PROTOMER TECHNOLOGIES INC. | 2024-12-05 | — | — | US | disclosed |
| US-12139502-B2 | Aromatic boron-containing compounds and related insulin analogs | PROTOMER TECHNOLOGIES INC. (US) | 2024-11-12 | — | — | US | disclosed |
| WO-2024215876-A2 | COMPOUNDS CONTAINING ONE OR MORE DIBORONATES AND RELATED INSULIN ANALOGS | PROTOMER TECHNOLOGIES, INC. (US) | 2024-10-17 | — | — | WO | disclosed |
| WO-2023225534-A1 | AROMATIC BORON-CONTAINING COMPOUNDS AND RELATED INSULIN ANALOGS | PROTOMER TECHNOLOGIES INC. (US) | 2023-11-23 | — | — | WO | disclosed |
| US-20230374045-A1 | AROMATIC BORON-CONTAINING COMPOUNDS AND RELATED INSULIN ANALOGS | PROTOMER TECHNOLOGIES INC. | 2023-11-23 | — | — | US | disclosed |
| WO-2023220280-A1 | RADIATION CLEAVED DRUG-CONJUGATE LINKERS ENABLE LOCAL PAYLOAD RELEASE SCLEROSIS | THE GENERAL HOSPITAL CORPORATION (US) | 2023-11-16 | — | — | WO | disclosed |
| EP-4108675-A1 | PREPARATION AND USE OF IMMUNOSTIMULATORY COUPLING COMPLEX WHICH IS DELIVERED AND ACTIVATED IN TARGETED MANNER | Yafei Shanghai Biolog Medicine Science & Technology Co., Ltd. (CN) | 2022-12-28 | — | — | EP | disclosed |
| US-11319341-B2 | Immune-stimulating soluble doxorubicin-conjugated complex | YAFEI (SHANGHAI) BIOPHARMACEUTICAL CO., LTD. (CN) | 2022-05-03 | — | — | US | disclosed |
| US-10995004-B2 | Method for functionalizing carbon nanoparticles and compositions | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2021-05-04 | — | — | US | disclosed |
| US-20200247842-A1 | Immune-stimulating soluble doxorubicin-conjugated complex | YAFEI (SHANGHAI) BIOPHARMACEUTICAL CO LTD (CN) | 2020-08-06 | — | — | US | disclosed |
| US-20200207627-A1 | METHOD FOR FUNCTIONALIZING CARBON NANOPARTICLES AND COMPOSITIONS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2020-07-02 | — | — | US | disclosed |
| WO-2018064504-A1 | METHOD FOR FUNCTIONALIZING CARBON NANOPARTICLES AND COMPOSITIONS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2018-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200247842-A1 | Immune-stimulating soluble doxorubicin-conjugated complex | TLR3, CD40, TLR6 | MGLL 2586/4885FAAH 1574/4885ALDH1A1 3933/4885 |
| US-20200207627-A1 | METHOD FOR FUNCTIONALIZING CARBON NANOPARTICLES AND COMPOSITIONS | TERT, CA13, PCCA | MGLL 3744/4885FAAH 1844/4885ALDH1A1 796/4885 |
| US-11319341-B2 | Immune-stimulating soluble doxorubicin-conjugated complex | TLR3, CD40, TLR6 | MGLL 2586/4885FAAH 1574/4885ALDH1A1 3933/4885 |
| US-10995004-B2 | Method for functionalizing carbon nanoparticles and compositions | TERT, CA13, PCCA | MGLL 3744/4885FAAH 1844/4885ALDH1A1 796/4885 |
| US-20250302968-A1 | RADIATION CLEAVED DRUG-CONJUGATE LINKERS ENABLE LOCAL PAYLOAD RELEASE SCLEROSIS | HIF1A, HIF1AN, DCLRE1A | MGLL 4599/4885FAAH 1781/4885ALDH1A1 2425/4885 |
| US-20240425528-A1 | AROMATIC BORON-CONTAINING COMPOUNDS AND RELATED INSULIN ANALOGS | IAPP, GPR119, INSR | MGLL 3112/4885FAAH 4658/4885ALDH1A1 4080/4885 |
| US-20240400637-A1 | COMPOUNDS CONTAINING ONE OR MORE DIBORONATES AND RELATED INSULIN ANALOGS | GPR119, INSR, IAPP | MGLL 937/4885FAAH 4284/4885ALDH1A1 2131/4885 |
| US-12139502-B2 | Aromatic boron-containing compounds and related insulin analogs | IAPP, GPR119, INSR | MGLL 3112/4885FAAH 4658/4885ALDH1A1 4080/4885 |
| US-20230374045-A1 | AROMATIC BORON-CONTAINING COMPOUNDS AND RELATED INSULIN ANALOGS | IAPP, GPR119, INSR | MGLL 3112/4885FAAH 4658/4885ALDH1A1 4080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.